Company Overview:
Chong Kun Dang Pharmaceutical (CKD) manufactures, distributes and markets pharmaceutical products.
The company develops a range of pharmaceutical products such as prescription drugs, OTC (over-the-counter) drugs and other products.
CKD offers a range of prescription drugs such as Umscomin syrup, Monolair fine granule, Penpol capsule, Lipidem injection, Izarbelltan 300mg (milligram), Xenical, Kmoxilin 625mg(milligram) tab, Belotaxel 20mg and Docetaxel 80mg.
The company provides various OTC drugs such as Naxen, Incolamin special tablet, Tyrosur gel, Famidine tablet, Terbelme, Gowoonzyme, Dongeugo, Throwpainbell, Tyrosur Gel, WondercalD chewable tablet, Incolamin premier tablet and Riewpap.
In addition, CKD offers a range of other products including Zzong Q aerosol, Zzong mosquito coils, Zzong mat vaporizer, Zzong liquid, Zzong Cockroach and Zzong ant.
Scope of the Report
- About the Company - Historical Details, Current Ownership Structure and basic overview of Chong Kun Dang Pharmaceutical Corp. in terms of revenue, net income, and operating income.
- Financials - Details about Chong Kun Dang Pharmaceutical Corp. listing status, annual financial reports (for the past 5 years), key financial highlights and region wise and category wise breakdown of their net revenue.
- Products / Services - Listing of the company’s entire portfolio along with description of individual products / services providing a clear picture of their target audience.
- Company SWOT Analysis - Outlines Chong Kun Dang Pharmaceutical Corp.’s strengths, weaknesses, and opportunities and threats facing the company.
- Recent Developments - Showcases Chong Kun Dang Pharmaceutical Corp.’s recent developments including mergers, acquisitions, partnerships, collaborations, new product launches, investment and divestment plans.
- Strategic Evaluation - Provides an overview of Chong Kun Dang Pharmaceutical Corp.’s corporate goals and strategic initiatives and evaluates their outcomes along with outlining any persisting legal issues and outlook of our in-house analyst panel on the particular company.
- Technology Landscape - Details how the company allocates its IT budget across the core areas of its business, CIO/CTO Profile, Key IT Initiatives and Deals undertaken buy the company at present along with outlook.
Key Questions Answered
- What domain does Chong Kun Dang Pharmaceutical Corp. operate and what are key points about it?
- What is the product / service portfolio of Chong Kun Dang Pharmaceutical Corp.?
- How has Chong Kun Dang Pharmaceutical Corp. performed financially from the 2013?
- How does Chong Kun Dang Pharmaceutical Corp. rank among its peers in terms of revenue and market share?
- What are Chong Kun Dang Pharmaceutical Corp. strengths and weaknesses and what opportunities and threats does it face?
- What are Chong Kun Dang Pharmaceutical Corp.’s main growth strategies and how successful has the company been at implementing them?
- What is the in-house technical capability of Chong Kun Dang Pharmaceutical Corp.? Where does it procure / outsource it?
Reasons to buy
- Report delivered in easily accessible PPT format which can be used to gain insights quickly and further prepare presentations of your own
- Lean pricing structure ultimately giving you vast access to the unlimited knowledge repository of the company profiles at very competitive cost
- 12 hour delivery time fulfilling your urgent requests as per your requirement
- On-demand customization options that can completely cater to your needs by focusing the report onto given specifics
1. About the Company
1.1 History and Basic Facts
1.2 Ownership Structure and Key Executives
1.3 Head Office
1.4 Other Locations & Subsidiaries
1.5 List of Competitors
1.6 Employee Count & Distribution
2. Financials
2.1 Company Type (Listed / Unlisted)
2.2 Annual Statements
2.3 Key Financial Highlights
2.4 Region-wise Breakdown
3. Product / Services
3.1 Overview
3.2 Description
4. SWOT Analysis
4.1 SWOT Overview
4.2 Strengths
4.3 Weaknesses
4.4 Opportunities
4.5 Threats
5. Recent Developments
5.1 Mergers & Acquisitions
5.2 Partnerships, Collaborations & Joint Ventures
5.3 New Product Launches
5.4 Business Expansion / Divestment
6. Strategic Evaluation
6.1 Corporate Strategy
6.2 Legal Issues
6.3 Analyst Outlook
7. Technology Landscape
7.1 Industry
7.1.1 Industry Snapshot
7.1.2 IT Spend
7.1.3 Key Information Technology Trends
7.2 Company
7.2.1 IT Overview
7.2.2 Key IT Technologies
7.2.3 Recent IT Initiatives
7.2.4 IT Outsourcing Engagements
7.2.5 Key IT Management
7.2.6 CIO/CTO Profile
Appendix
- Methodology
- About Us
- Contact Us
- Disclaimer